Suppr超能文献

长链非编码 RNA SNHG16 通过与 hsa-miR-124-3p 的反向作用在急性淋巴细胞白血病中具有肿瘤抑制作用。

Long non-coding RNA SNHG16 has Tumor suppressing effect in acute lymphoblastic leukemia by inverse interaction on hsa-miR-124-3p.

机构信息

Department of Hematology, Zhejiang Province People's Hospital, Hangzhou, 310014, China.

出版信息

IUBMB Life. 2019 Jan;71(1):134-142. doi: 10.1002/iub.1947. Epub 2018 Oct 31.

Abstract

Acute lymphoblastic leukemia (ALL) is one of the deadly forms of childhood cancers in the world. In the present study, we used both in vitro and in vivo models to evaluate the functional mechanisms of a long noncoding RNA (lncRNA), small nucleolar RNA host gene 16 (SNHG16) in ALL. SNHG16 gene expression was evaluated by quantitative real-time PCR (qPCR) in both in vitro ALL cell lines and in vivo human samples of T lymphocytes. Lentivirus-mediated SNHG16 downregulation was performed in MOLT3 and SUP-B15 cells, to evaluate its functional effects on ALL cell proliferation, migration in vitro, and ALL transplant in vivo. Epigenetic regulation of SNHG16 on human miR-124-3p (hsa-miR-124-3p) was evaluated by dual-luciferase activity assay and qPCR. Hsa-miR-124-3p was inhibited in SNHG16-downregulated MOLT3 and SUP-B15 cells to further evaluate the functional correlation between SNHG16 and hsa-miR-124-3p in ALL. SNHG16 is upregulated in both in vitro ALL cell lines and in vivo human leukemic T-cells. SNHG16 downregulation suppressed ALL proliferation and migration in vitro, and ALL explant in vivo. Hsa-miR-124-3p was demonstrated to interact with SNHG16, and upregulated in SNHG16-downregulated ALL cells. In addition, inhibiting hsa-miR-124-3p reversed SNHG16-downregulation-mediated tumor suppressive functions in ALL. SNHG16 is upregulated in ALL, and its inhibition has tumor suppressive effect in ALL, likely through epigenetic interaction on hsa-miR-124-3p. © 2018 IUBMB Life, 71(1):134-142, 2019.

摘要

急性淋巴细胞白血病(ALL)是世界上儿童癌症中最致命的形式之一。在本研究中,我们使用体外和体内模型来评估长非编码 RNA(lncRNA),小核仁 RNA 宿主基因 16(SNHG16)在 ALL 中的功能机制。通过定量实时 PCR(qPCR)评估体外 ALL 细胞系和体内 T 淋巴细胞人类样本中 SNHG16 基因的表达。在 MOLT3 和 SUP-B15 细胞中进行慢病毒介导的 SNHG16 下调,以评估其对 ALL 细胞增殖、体外迁移和体内 ALL 移植的功能影响。通过双荧光素酶活性测定和 qPCR 评估 SNHG16 对人类 miR-124-3p(hsa-miR-124-3p)的表观遗传调控。在 SNHG16 下调的 MOLT3 和 SUP-B15 细胞中抑制 hsa-miR-124-3p,以进一步评估 SNHG16 和 hsa-miR-124-3p 在 ALL 中的功能相关性。SNHG16 在体外 ALL 细胞系和体内人类白血病 T 细胞中均上调。SNHG16 下调抑制体外 ALL 增殖和迁移,以及体内 ALL 外植体。证明 hsa-miR-124-3p 与 SNHG16 相互作用,并在 SNHG16 下调的 ALL 细胞中上调。此外,抑制 hsa-miR-124-3p 逆转了 SNHG16 下调介导的 ALL 中的肿瘤抑制功能。SNHG16 在 ALL 中上调,其抑制作用具有 ALL 的肿瘤抑制作用,可能通过对 hsa-miR-124-3p 的表观遗传相互作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验